investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia
Tait D Shanafelt
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Curtis Hanson
Mayo Clinic (Rochester)
Rochester, United States
Braggio Esteban
Mayo Clinic (Rochester)
Rochester, United States
Alan Ramsay
King's College London
London, United Kingdom
Neil E Kay
Mayo Clinic (Rochester)
Rochester, United States
Xin Wang
Dana-Farber Cancer Institute
Boston, United States
University of Manchester
Manchester, United Kingdom
Tait D Shanafelt
Mayo Clinic (Rochester)
Rochester, United States
Related projects
Peter Aplan
Collaborative Pathways that Lead to Leukemia – Rockville
Leukaemia
Hematology and hematologic malignancies
Marc Nicklaus
In Silico Screening for Cancer Targets
Leukaemia
Hematology and hematologic malignancies
George Calin
Deciphering the Role of Non-coding RNA in Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Michael R Green
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Collaborative Pathways that Lead to Leukemia
Leukaemia
Hematology and hematologic malignancies
H Leighton Grimes
Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias
Leukaemia
Hematology and hematologic malignancies
Robert Kreitman
Development of Recombinant Toxins to Treat Hematologic Malignancies
Leukaemia
Hematology and hematologic malignancies
Ashley Marie Pandolfi
Unraveling crucial roles of homeobox gene Hlx in hematopoiesis and leukemogenesis
Leukaemia
Hematology and hematologic malignancies
